Tetrahydrofuran → 3-{[3-{[(5-Chloro-2-thienyl)sulfonyl]amino}-4-(methyloxy)-1H-indazol-1-yl]methyl}benzamide

HRID 1808609Notes

Reaction equation

HRID 1808609 reaction equation
[Cl:1][C:2]1[S:6][C:5]([S:7]([N:10]([C:19]2[C:27]3[C:22](=[CH:23][CH:24]=[CH:25][C:26]=3[O:28][CH3:29])[NH:21][N:20]=2)COCC[Si](C)(C)C)(=[O:9])=[O:8])=[CH:4][CH:3]=1.C(=O)([O-])[O-].[K+].[K+].Cl[CH2:37][C:38]1[CH:39]=[C:40]([CH:44]=[CH:45][CH:46]=1)[C:41]([NH2:43])=[O:42].N1C2C(=CC=CC=2)C=N1.CCCC[N+](CCCC)(CCCC)CCCC.[F-].C1COCC1>C(Cl)Cl.O.CN(C=O)C>[Cl:1][C:2]1[S:6][C:5]([S:7]([NH:10][C:19]2[C:27]3[C:22](=[CH:23][CH:24]=[CH:25][C:26]=3[O:28][CH3:29])[N:21]([CH2:37][C:38]3[CH:39]=[C:40]([CH:44]=[CH:45][CH:46]=3)[C:41]([NH2:43])=[O:42])[N:20]=2)(=[O:9])=[O:8])=[CH:4][CH:3]=1

Participants

10

Conditions

Temperature
50 °C

Procedure

To a solution of 5-chloro-N-[4-(methyloxy)-1H-indazol-3-yl]-N-({[2-(trimethylsilyl)ethyl]oxy}methyl)-2-thiophenesulfonamide (for a preparation see Intermediate 8) (150 mg, 0.316 mmol) into DMF (2 mL) was added at ambient temperature potassium carbonate (87 mg, 0.63 mmol) and 3-(chloromethyl)benzamide (Maybridge)(64.4 mg, 0.380 mmol). The resulting mixture was stirred at 50° C. overnight, and then diluted with DCM (2 mL) and water (2 mL). The organic mixture was partitioned and the aqueous layer was further extracted with 2 mL of DCM. The organic solutions were combined together, dried over an hydrophobic frit and evaporated under a nitrogen stream in a blowdown unit. The crude product was judged by LCMS to be pure enough to be engaged in the next step without any further purification. LCMS (System A) RT=1.37 min, ES+ve m/z 607/609 (M+H)+. In a 2 to 5 mL Biotage microwave vial were added the crude indazole product and TBAF solution in THF (1M, 3.16 mL, 3.16 mmol). The reaction vessel was sealed and heated in a Biotage Initiator at 110° C. for 10 min (very high absorption level). The crude mixture was then diluted with 2 mL of DCM and 2 mL of water. The organic layer was separated and the aqueous layer was further extracted with 2 mL of DCM. The combined organic solutions were dried over an hydrophobic frit, and evaporated under a nitrogen stream in a blowdown unit. The residue was dissolved in 1:1 MeOH:DMSO (1 mL) and purified by MDAP (supelcosil ABZ+Plus column) eluting with solvents A/B (A: Water+0.1% Formic acid, B: MeCN:Water 95:5+0.05% Formic acid). The solvent was removed under a stream of nitrogen in a Radleys blowdown apparatus to give the title compound (76 mg, 50%). LCMS (System A) RT=0.97 min, ES+ve m/z 477/479 (M+H)+.

Workup

  1. customThe organic mixture was partitioned
  2. extractionthe aqueous layer was further extracted with 2 mL of DCM
  3. customdried over an hydrophobic frit
  4. customevaporated under a nitrogen stream in a blowdown unit
  5. customto be engaged in the next step without any further purification
  6. customThe reaction vessel was sealed
  7. temperatureheated in a Biotage Initiator at 110° C. for 10 min (very high absorption level)
  8. customThe organic layer was separated
  9. extractionthe aqueous layer was further extracted with 2 mL of DCM
  10. customThe combined organic solutions were dried over an hydrophobic frit
  11. customevaporated under a nitrogen stream in a blowdown unit
  12. dissolutionThe residue was dissolved in 1:1 MeOH
  13. customDMSO (1 mL) and purified by MDAP (supelcosil ABZ+Plus column)
  14. washeluting with solvents A/B (A: Water+0.1% Formic acid, B
  15. customThe solvent was removed under a stream of nitrogen in a Radleys blowdown apparatus

Sources & evidence

ORD record
ord-801e2838ce364046b3c850b24a28d5d6
Source dataset
uspto-grants-2013_01
Patent number
US08357716B2

Reaction notes

Loading…